Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Breems, DA
Boogaerts, MA
Dekker, AW
Van Putten, WLJ
Sonneveld, P
Huijgens, PC
Van der Lelie, J
Vellenga, E
Gratwohl, A
Verhoef, GEG
Verdonck, LF
Lowenberg, B

January 2005

The question as to whether autologous stem cell transplantation (SCT) after consolidation chemothera...

Hematopoietic stem cell transplantation for patients with AML in first complete remission

Cornelissen, Jan
Blaise, D

January 2016

Postremission therapy in patients with acute myeloid leukemia (AML) may consist of continuing chemot...

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients

Jackson, Kathryn
Kennedy, Glen
Mollee, Peter
Marlton, Paula
Morris, Kirk

September 2014

Aims: Acute myeloid leukemia (AML) incidence increases with age, yet treatment of elderly patients h...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

Thomas, X
Suciu, S
Rio, B
Leone, G
Broccia, G
Fillet, G
Jehn, U
Feremans, W
Meloni, G
Vignetti, M
De Witte, T
AMADORI, SERGIO

January 2007

Background and Objectives The optimal post-remission treatment for elderly patients with acute myelo...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: Results of the prospective EORTC-GIMEMA AML-13 study

Thomas, Xavier
Suciu, Stefan
Rio, Bernard
Leone, Giuseppe
Broccia, Giorgio
Fillet, George
Jehn, Ulrich
Feremans, Walter
Meloni, Giovanna
Vignetti, Marco
De Witte, Theo
Amadori, Sergio

March 2007

Background and Objectives: The optimal post-remission treatment for elderly patients with acute myel...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

Thomas, X.
Suciu, S.
Rio, B.
Leone, G.
Broccia, G.
Fillet, G.
Jehn, U.
Feremans, W.
Meloni, G.
Vignetti, M.
Witte, T.J.M. de
Amadori, S.

January 2007

BACKGROUND AND OBJECTIVES: The optimal post-remission treatment for elderly patients with acute myel...

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

Gert J. Ossenkoppele
Jeroen J.W.M. Janssen
Peter C. Huijgens

February 2013

Treatment outcome in elderly Acute Myeloid Leukemia (AML) is still very disappointing. Although comp...

Autologous Transplantation for Older Adults with AML

Beatrice U. Mueller
Katja Seipel
Ulrike Bacher
Thomas Pabst

September 2018

While the majority of patients with acute myeloid leukemia (AML) are above the age of 65 years at di...

Autologous Hematopoietic Stem Cell Transplantation as an Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myelogenous Leukemia

Jung, Andre S.
Holman, Peter R.
Castro, Januario E.
Carrier, Ewa K.
Bashey, Asad
Lane, Thomas A.
Nelson, Connie L.
Pu, Minya
Messer, Karen
Corringham, Sue M.
Ball, Edward D.

October 2009

Autologous peripheral blood stem/progenitor cell transplantation (APBSCT) has been investigated as a...

Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.

Heini, Alexander D
Berger, Martin Dave
Seipel, Katja
Mansouri Taleghani, Behrouz
Baerlocher, Gabriela M.
Leibundgut, Kurt
Banz Wälti, Yara
Novak, Urban
Pabst, Thomas

January 2017

The outcome of AML patients ≥65 years remains disappointing. Current post-induction strategies for e...

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission:a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Breems, DA
Boogaerts, MA
Dekker, AW
Van Putten, WLJ
Sonneveld, P
Huijgens, PC
Van der Lelie, J
Vellenga, E
Gratwohl, A
Verhoef, GEG
Verdonck, LF
Lowenberg, B

January 2005

The question as to whether autologous stem cell transplantation (SCT) after consolidation chemothera...

Long-term Outcome of Autologous Transplantation of Peripheral Blood Progenitor Cells as Postremission Management of Patients ≥60 Years with Acute Myelogenous Leukemia

Lashkari, Ashkan
Lowe, Tom
Collisson, Eric
Paquette, Ronald
Emmanouilides, Christos
Territo, Mary
Schiller, Gary

April 2006

AbstractThe optimal postremission treatment for elderly patients with acute myelogenous leukemia (AM...

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia

Hałaburda, Kazimierz

August 2021

The incidence of acute myeloid leukemia (AML) significantly increases with age. Most AML patients ar...

Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia.

SERVAIS, Sophie
BEGUIN, Yves
BARON, Frédéric

May 2022

peer reviewedAs in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best...

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Vellenga, Edo
van Putten, Wim
Ossenkoppele, Gert J.
Verdonck, Leo F.
Theobald, Matthias
Cornelissen, Jan J.
Huijgens, Peter C.
Maertens, Johan
Gratwohl, Alois
Schaafsma, Ron
Schanz, Urs
Graux, Carlos
Schouten, Harry C.
Ferrant, Augustin
Bargetzi, Mario
Fey, Martin F.
Löwenberg, Bob

January 2011

We report the results of a prospective, randomized phase 3 trial evaluating autologous peripheral bl...

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Breems, DA
Boogaerts, MA
Dekker, AW
Van Putten, WLJ
Sonneveld, P
Huijgens, PC
Van der Lelie, J
Vellenga, E
Gratwohl, A
Verhoef, GEG
Verdonck, LF
Lowenberg, B

January 2005

The question as to whether autologous stem cell transplantation (SCT) after consolidation chemothera...

Hematopoietic stem cell transplantation for patients with AML in first complete remission

Cornelissen, Jan
Blaise, D

January 2016

Postremission therapy in patients with acute myeloid leukemia (AML) may consist of continuing chemot...

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients

Jackson, Kathryn
Kennedy, Glen
Mollee, Peter
Marlton, Paula
Morris, Kirk

September 2014

Aims: Acute myeloid leukemia (AML) incidence increases with age, yet treatment of elderly patients h...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

Thomas, X
Suciu, S
Rio, B
Leone, G
Broccia, G
Fillet, G
Jehn, U
Feremans, W
Meloni, G
Vignetti, M
De Witte, T
AMADORI, SERGIO

January 2007

Background and Objectives The optimal post-remission treatment for elderly patients with acute myelo...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: Results of the prospective EORTC-GIMEMA AML-13 study

Thomas, Xavier
Suciu, Stefan
Rio, Bernard
Leone, Giuseppe
Broccia, Giorgio
Fillet, George
Jehn, Ulrich
Feremans, Walter
Meloni, Giovanna
Vignetti, Marco
De Witte, Theo
Amadori, Sergio

March 2007

Background and Objectives: The optimal post-remission treatment for elderly patients with acute myel...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

Thomas, X.
Suciu, S.
Rio, B.
Leone, G.
Broccia, G.
Fillet, G.
Jehn, U.
Feremans, W.
Meloni, G.
Vignetti, M.
Witte, T.J.M. de
Amadori, S.

January 2007

BACKGROUND AND OBJECTIVES: The optimal post-remission treatment for elderly patients with acute myel...

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

Gert J. Ossenkoppele
Jeroen J.W.M. Janssen
Peter C. Huijgens

February 2013

Treatment outcome in elderly Acute Myeloid Leukemia (AML) is still very disappointing. Although comp...

Autologous Transplantation for Older Adults with AML

Beatrice U. Mueller
Katja Seipel
Ulrike Bacher
Thomas Pabst

September 2018

While the majority of patients with acute myeloid leukemia (AML) are above the age of 65 years at di...

Autologous Hematopoietic Stem Cell Transplantation as an Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myelogenous Leukemia

Jung, Andre S.
Holman, Peter R.
Castro, Januario E.
Carrier, Ewa K.
Bashey, Asad
Lane, Thomas A.
Nelson, Connie L.
Pu, Minya
Messer, Karen
Corringham, Sue M.
Ball, Edward D.

October 2009

Autologous peripheral blood stem/progenitor cell transplantation (APBSCT) has been investigated as a...

Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.

Heini, Alexander D
Berger, Martin Dave
Seipel, Katja
Mansouri Taleghani, Behrouz
Baerlocher, Gabriela M.
Leibundgut, Kurt
Banz Wälti, Yara
Novak, Urban
Pabst, Thomas

January 2017

The outcome of AML patients ≥65 years remains disappointing. Current post-induction strategies for e...

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission:a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Breems, DA
Boogaerts, MA
Dekker, AW
Van Putten, WLJ
Sonneveld, P
Huijgens, PC
Van der Lelie, J
Vellenga, E
Gratwohl, A
Verhoef, GEG
Verdonck, LF
Lowenberg, B

January 2005

The question as to whether autologous stem cell transplantation (SCT) after consolidation chemothera...

Long-term Outcome of Autologous Transplantation of Peripheral Blood Progenitor Cells as Postremission Management of Patients ≥60 Years with Acute Myelogenous Leukemia

Lashkari, Ashkan
Lowe, Tom
Collisson, Eric
Paquette, Ronald
Emmanouilides, Christos
Territo, Mary
Schiller, Gary

April 2006

AbstractThe optimal postremission treatment for elderly patients with acute myelogenous leukemia (AM...

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia

Hałaburda, Kazimierz

August 2021

The incidence of acute myeloid leukemia (AML) significantly increases with age. Most AML patients ar...

Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia.

SERVAIS, Sophie
BEGUIN, Yves
BARON, Frédéric

May 2022

peer reviewedAs in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best...

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Vellenga, Edo
van Putten, Wim
Ossenkoppele, Gert J.
Verdonck, Leo F.
Theobald, Matthias
Cornelissen, Jan J.
Huijgens, Peter C.
Maertens, Johan
Gratwohl, Alois
Schaafsma, Ron
Schanz, Urs
Graux, Carlos
Schouten, Harry C.
Ferrant, Augustin
Bargetzi, Mario
Fey, Martin F.
Löwenberg, Bob

January 2011

We report the results of a prospective, randomized phase 3 trial evaluating autologous peripheral bl...

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

Breems, DA
Boogaerts, MA
Dekker, AW
Van Putten, WLJ
Sonneveld, P
Huijgens, PC
Van der Lelie, J
Vellenga, E
Gratwohl, A
Verhoef, GEG
Verdonck, LF
Lowenberg, B

January 2005

The question as to whether autologous stem cell transplantation (SCT) after consolidation chemothera...

Hematopoietic stem cell transplantation for patients with AML in first complete remission

Cornelissen, Jan
Blaise, D

January 2016

Postremission therapy in patients with acute myeloid leukemia (AML) may consist of continuing chemot...

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients

Jackson, Kathryn
Kennedy, Glen
Mollee, Peter
Marlton, Paula
Morris, Kirk

September 2014

Aims: Acute myeloid leukemia (AML) incidence increases with age, yet treatment of elderly patients h...

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

Abstract

Extracted data

Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study

Abstract

Extracted data

Related items

Related items